Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study
References (31)
- et al.
Ambulatory patients with community-acquired pneumonia: The frequency of atypical agents and clinical course
Am J Med
(1996) - et al.
Comparative clinical and laboratory features of Legionella with pneumococcal and Mycoplasma pneumonias
Br J Dis Chest
(1987) - et al.
Microbial etiology of acute pneumonia in hospitalized patients
Chest
(1992) - et al.
Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a multicenter national comparative activity surveillance study. The ofloxacin surveillance group
Diagn Microbiol Infect Dis
(1992) Inpatient utilization of short-stay hospital by diagnosis
(1983)- et al.
Community-acquired pneumonia
Curr Clin Top Infect Dis
(1996) - et al.
New and emerging etiologies for community-acquired pneumonia with implications for therapy: A prospective multicenter study of 359 cases
Medicine
(1990) Community-acquired pneumonia
Clin Infect Dis
(1994)- et al.
Bacterial pneumonia during the Hong Kong influenza epidemic of 1968–1969. Experience in a city-county hospital
Arch Intern Med
(1971)
Prediction of microbial aetiology at admission to hospital for pneumonia from the presenting clinical features
Thorax
(1989)
Guidelines for the initial management of adults with community-acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy
Am Rev Respir Dis
(1993)
Emergence of drug-resistant pneumococcal infections in the United States
JAMA
(1994)
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae
NEJM
(1994)
In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens
Chemotherapy
(1993)
Cited by (0)
Copyright © 1997 Published by Elsevier Inc.